Halberd also cures obesity with his method! Halberd’s PTSD/Alzheimer’s R&D Reveals Link to Potential Obesity Cure
Jackson Center, PA, October 20, 2021 – Halberd Corporation's (OTC PINK: "HALB") ongoing research into discovering treatments/cures for PTSD, Alzheimer’s Disease, and other neurodegenerative diseases has led to a potential breakthrough in the battle against obesity. Research has indicated inflammatory cytokines present in the Cerebral Spinal Fluid (CSF) of neurodegenerative disease patients are also found in the blood of those suffering from obesity.
Halberd’s patent-pending extracorporeal treatment for removing the disease antigens, excess proteins and cytokines from CSF associated with neurodegenerative diseases can similarly be applied to eliminating the chemical imbalances in blood believed to be responsible for obesity.
Removal of these elements from blood would therefore reduce or eliminate the negative health issues associated with obesity, such as high blood pressure, diabetes, heart disease, stroke, cancer, etc. It has been known for several years that obesity is linked to higher risks of death.
Further research is underway with Halberd’s university partners.
William A. Hartman, Chairman, President and CEO of Halberd Corporation, stated, “Our plans to pursue cures for PTSD and Alzheimer’s Disease involve the removal of select inflammatory cytokines from CSF and blood plasma.
We are rapidly pursuing elimination of these target pathogens from CSF and intend to address removal from blood plasma as soon as possible.
What is exciting about this development concerning obesity is that our scientists didn’t have to initiate any new experimentations, but rather relied on numerous medical articles to affirm our direction.”
https://halberdcorporation.com/news/